We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FRPT icon
76
Freshpet
FRPT
$3.51B
$17.2M 0.28%
125,713
+9,904
+9% +$1.3M
FL
77
DELISTED
Foot Locker
FL
$16.9M 0.27%
+655,000
New +$18.1M
IMVT icon
78
CALL
Immunovant
IMVT
$8.06B
$16.5M 0.26%
+580,000
New +$17.1M
CPB icon
79
Campbell Soup
CPB
$6.87B
$16.4M 0.26%
335,473
-732,441
-69% -$35.6M
ADBE icon
80
Adobe
ADBE
$103B
$16.2M 0.26%
31,382
+3,233
+11% +$1.77M
LOW icon
81
Lowe's Companies
LOW
$123B
$14.4M 0.23%
53,035
-24,443
-32% -$5.92M
RMTI icon
82
Rockwell Medical
RMTI
$28.7M
$14.2M 0.23%
358,153
+35,989
+11% +$968K
RVTY icon
83
Revvity
RVTY
$12.8B
$13.7M 0.22%
107,486
+12,306
+13% +$1.45M
TSM icon
84
TSMC
TSM
$2.15T
$13M 0.21%
75,000
+15,000
+25% +$2.56M
UBER icon
85
Uber
UBER
$139B
$11.9M 0.19%
157,816
-107,078
-40% -$7.54M
EAT icon
86
Brinker International
EAT
$9.69B
$11.7M 0.19%
153,156
-40,466
-21% -$2.79M
HELE icon
87
Helen of Troy
HELE
$689M
$11.5M 0.18%
+186,000
New +$11M
ENR icon
88
Energizer
ENR
$1.54B
$11.2M 0.18%
+351,594
New +$10.6M
EW icon
89
Edwards Lifesciences
EW
$51.2B
$10.9M 0.17%
+164,995
New +$12M
BILL icon
90
BILL Holdings
BILL
$4.81B
$10.8M 0.17%
204,776
-275,188
-57% -$14.2M
ULTA icon
91
Ulta Beauty
ULTA
$23.2B
$10.7M 0.17%
27,409
-20,550
-43% -$7.71M
MDGL icon
92
Madrigal Pharmaceuticals
MDGL
$11.9B
$10.6M 0.17%
49,915
-100,085
-67% -$25.6M
ENTA icon
93
Enanta Pharmaceuticals
ENTA
$384M
$10.4M 0.17%
1,000,000
-96,000
-9% -$1.26M
CHDN icon
94
Churchill Downs
CHDN
$6.02B
$10.3M 0.16%
76,033
-48,221
-39% -$6.67M
WYNN icon
95
Wynn Resorts
WYNN
$10.5B
$9.67M 0.15%
+100,887
New +$8.11M
XNCR icon
96
Xencor
XNCR
$1.47B
$9.61M 0.15%
478,000
-386,000
-45% -$7.25M
CRSP icon
97
CRISPR Therapeutics
CRSP
$5.17B
$9.4M 0.15%
200,000
+1,643
+0.8% +$83.4K
LIVN icon
98
LivaNova
LIVN
$4.29B
$8.96M 0.14%
+170,477
New +$8.45M
LVS icon
99
Las Vegas Sands
LVS
$29.7B
$8.81M 0.14%
+175,100
New +$7.18M
CKPT
100
DELISTED
Checkpoint Therapeutics
CKPT
$8.7M 0.14%
3,886,000
+1,380,000
+55% +$3.18M
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.